オンコリスバイオファーマの株価時系列
日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
---|---|---|---|---|---|---|---|
2020/10/23 | 1,707 | 1,743 | 1,643 | 1,730 | +16 | +0.9% | 350,400 |
2020/10/22 | 1,750 | 1,750 | 1,694 | 1,714 | -48 | -2.7% | 328,900 |
2020/10/21 | 1,737 | 1,796 | 1,737 | 1,762 | ±0 | ±0% | 168,500 |
2020/10/20 | 1,799 | 1,813 | 1,741 | 1,762 | -65 | -3.6% | 301,500 |
2020/10/19 | 1,785 | 1,836 | 1,736 | 1,827 | +43 | +2.4% | 274,900 |
2020/10/16 | 1,975 | 1,982 | 1,770 | 1,784 | -195 | -9.9% | 992,400 |
2020/10/15 | 1,998 | 2,012 | 1,961 | 1,979 | -29 | -1.4% | 333,300 |
2020/10/14 | 2,017 | 2,035 | 2,003 | 2,008 | -17 | -0.8% | 185,300 |
2020/10/13 | 2,040 | 2,040 | 2,000 | 2,025 | -21 | -1% | 217,800 |
2020/10/12 | 2,038 | 2,062 | 2,021 | 2,046 | +1 | ±0% | 161,100 |
2020/10/09 | 2,100 | 2,114 | 2,031 | 2,045 | -56 | -2.7% | 285,500 |
2020/10/08 | 2,101 | 2,126 | 2,076 | 2,101 | +16 | +0.8% | 171,500 |
2020/10/07 | 2,130 | 2,134 | 2,077 | 2,085 | -62 | -2.9% | 213,200 |
2020/10/06 | 2,101 | 2,147 | 2,075 | 2,147 | +57 | +2.7% | 194,700 |
2020/10/05 | 2,110 | 2,126 | 2,077 | 2,090 | -2 | -0.1% | 188,500 |
2020/10/02 | 2,104 | 2,139 | 2,055 | 2,092 | - | - | 302,000 |
2020/10/01 | 0 | 0 | 0 | 0 | - | - | 0 |
2020/09/30 | 2,094 | 2,114 | 2,063 | 2,088 | -5 | -0.2% | 133,800 |
2020/09/29 | 2,020 | 2,094 | 2,020 | 2,093 | +72 | +3.6% | 150,600 |
2020/09/28 | 2,044 | 2,073 | 2,004 | 2,021 | -33 | -1.6% | 214,000 |
2020/09/25 | 2,041 | 2,084 | 2,032 | 2,054 | -12 | -0.6% | 159,300 |
2020/09/24 | 2,154 | 2,155 | 2,047 | 2,066 | -103 | -4.7% | 357,300 |
2020/09/23 | 2,123 | 2,172 | 2,112 | 2,169 | +4 | +0.2% | 186,800 |
2020/09/18 | 2,150 | 2,165 | 2,126 | 2,165 | +5 | +0.2% | 149,900 |
2020/09/17 | 2,182 | 2,184 | 2,112 | 2,160 | -13 | -0.6% | 302,100 |
2020/09/16 | 2,090 | 2,173 | 2,078 | 2,173 | +83 | +4% | 300,600 |
2020/09/15 | 2,076 | 2,099 | 2,052 | 2,090 | +14 | +0.7% | 124,700 |
2020/09/14 | 2,088 | 2,101 | 2,057 | 2,076 | +8 | +0.4% | 181,800 |
2020/09/11 | 2,041 | 2,072 | 1,991 | 2,068 | +57 | +2.8% | 238,900 |
2020/09/10 | 2,045 | 2,061 | 1,998 | 2,011 | -29 | -1.4% | 159,800 |
2020/09/09 | 2,000 | 2,046 | 1,998 | 2,040 | -7 | -0.3% | 150,300 |
2020/09/08 | 1,994 | 2,055 | 1,971 | 2,047 | +53 | +2.7% | 249,400 |
2020/09/07 | 2,030 | 2,041 | 1,961 | 1,994 | -29 | -1.4% | 304,900 |
2020/09/04 | 2,027 | 2,061 | 2,011 | 2,023 | -47 | -2.3% | 281,500 |
2020/09/03 | 2,056 | 2,113 | 2,035 | 2,070 | +19 | +0.9% | 248,100 |
2020/09/02 | 2,080 | 2,118 | 2,031 | 2,051 | -10 | -0.5% | 224,400 |
2020/09/01 | 2,053 | 2,078 | 2,029 | 2,061 | +11 | +0.5% | 163,100 |
2020/08/31 | 2,020 | 2,094 | 2,020 | 2,050 | +42 | +2.1% | 219,500 |
2020/08/28 | 2,090 | 2,098 | 1,990 | 2,008 | -90 | -4.3% | 545,400 |
2020/08/27 | 2,200 | 2,212 | 2,087 | 2,098 | -98 | -4.5% | 395,400 |
2020/08/26 | 2,190 | 2,233 | 2,163 | 2,196 | +32 | +1.5% | 274,400 |
2020/08/25 | 2,186 | 2,205 | 2,141 | 2,164 | -29 | -1.3% | 280,800 |
2020/08/24 | 2,263 | 2,273 | 2,158 | 2,193 | -70 | -3.1% | 409,400 |
2020/08/21 | 2,229 | 2,280 | 2,205 | 2,263 | +52 | +2.4% | 291,300 |
2020/08/20 | 2,282 | 2,290 | 2,185 | 2,211 | -72 | -3.2% | 394,800 |
2020/08/19 | 2,215 | 2,283 | 2,183 | 2,283 | +70 | +3.2% | 324,100 |
2020/08/18 | 2,160 | 2,224 | 2,130 | 2,213 | +54 | +2.5% | 272,300 |
2020/08/17 | 2,246 | 2,271 | 2,140 | 2,159 | -71 | -3.2% | 421,600 |
2020/08/14 | 2,263 | 2,329 | 2,207 | 2,230 | -30 | -1.3% | 547,100 |
2020/08/13 | 2,186 | 2,283 | 2,163 | 2,260 | +97 | +4.5% | 519,600 |
1001~
1050
件表示中 / 2679件
類似銘柄と比較する
現在ご覧いただいている「オンコリス」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
---|---|---|---|---|---|---|---|---|
オンコリス | 70,300円 | +58.7% | - | 0.00% | - | 12.39倍 |
|
腫瘍溶解ウイルス技術使うがん治療薬柱に感染症薬も開発。導出先が神経疾患薬を米国治験中 |
大幸薬品 | 36,400円 | +11.1% | - | 0.00% | 33.21倍 | 2.26倍 |
|
止瀉薬「正露丸」で有名な大衆薬中堅。オーナー経営色。不振の「クレベリン」など事業再構築中 |
ヘリオス | 19,600円 | +395.9% | - | 0.00% | - | 5.45倍 |
|
iPS細胞、体性幹細胞を活用する再生医薬品バイオベンチャー。住友ファーマと共同開発も |
Chordia | 24,900円 | - | - | 0.00% | - | 4.08倍 |
|
RNA制御ストレスを標的とする低分子抗がん薬を開発中。開発品・研究者は武田にルーツ |
CANBAS | 88,700円 | - | - | 0.00% | - | 7.35倍 |
|
抗がん剤開発に特化した創薬ベンチャー。主力の膵臓がん治療薬候補は自社開発。導出も模索 |
市場注目の銘柄
チャート関連のコラム